Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,298.00
Bid: 12,296.00
Ask: 12,300.00
Change: -66.00 (-0.53%)
Spread: 4.00 (0.033%)
Open: 12,358.00
High: 12,376.00
Low: 12,276.00
Prev. Close: 12,364.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-Taiwan says China blocked deal with BioNTech for COVID-19 shots

Wed, 26th May 2021 08:36

(Adds Taiwanese official seeking U.S. and EU help)

By Yimou Lee and Ben Blanchard

TAIPEI, May 26 (Reuters) - Taiwan directly accused China for
the first time on Wednesday of blocking a deal with Germany's
BioNTech SE for COVID-19 vaccines, in an escalating
war of words after Beijing offered the shots to the island via a
Chinese company.

Taiwan has millions of shots on order, from AstraZeneca Plc
and Moderna Inc, but has received only slightly
more than 700,000 to date, and has only been able to vaccinate
about 1% of its population as COVID-19 cases surge.

While Taiwan has previously said it had been unable to sign
a final contract with BioNTech, it had only implied that Chinese
pressure was to blame.

China claims Taiwan as its territory and frequently puts
pressure on countries and firms to curtail their dealings with
the island.

President Tsai Ing-wen told a meeting of her ruling
Democratic Progressive Party that orders for the AstraZeneca and
Moderna shots had been "smoothly" booked.

"As for Germany's BioNTech, we were close to completing the
contract with the original German plant, but because of China's
intervention, up to now there's been no way to complete it," she
said.

Taiwan, which has a population of more than 23 million
people, had bought nearly 30 million shots, Tsai said, without
giving details.

BioNTech, which sells its vaccine in partnership with Pfizer
Inc, declined to comment on Tsai's remarks, but added
"we are supportive of global vaccine supply".

China has denied trying to block vaccines for Taiwan and has
offered to provide them to the island as a goodwill gesture.

APPEALS FOR U.S., EU ASSISTANCE

Lily L.W. Hsu, secretary-general of Taiwan's Foreign
Ministry, called the Chinese offer "very divisive."

At an online event hosted by the German Marshall Fund of the
United States that also involved a U.S. and an EU official, Hsu
said Taiwan was developing its own vaccine, but the earliest
that would be ready for use was July. She repeated calls Taiwan
has made for U.S and EU assistance.

"Because of the recent outbreak we desperately need vaccines
... we do need assistance in getting vaccines before our
domestic vaccine is ready for use, she said.

The top U.S. diplomat in Taipei, Brent Christensen, said on
Wednesday he was confident Taiwan could control its spike in
COVID-19 cases, noting its infection numbers remained quite low.
He said the United States and Taipei were in talks on vaccines
but did not say shots were on the way.

China's Shanghai Fosun Pharmaceutical Group Co Ltd
said on Saturday it was willing to provide Taiwan
with BioNTech COVID-19 vaccines.

Fosun signed a deal with BioNTech to exclusively develop and
commercialise the vaccine developed using BioNTech's mRNA
technology in mainland China, Hong Kong, Macau and Taiwan.

But Tsai said the island would only buy directly from the
original manufacturers, or discuss purchases with them via the
COVAX global vaccine sharing scheme.

"Only by negotiating with the original manufacturer can you
obtain the original manufacturer's direct guarantee and
responsibility for quality and safety, so as to avoid legal and
political risks," she said.

Fosun did not respond to requests for comment.

China's foreign ministry said Taiwan's channels to receive
vaccines from them were "smooth", while China's Taiwan Affairs
Office said Taipei was using excuses to stop the shots.

China was "happy to see" Fosun's willingness to provide
vaccines to Taiwan, the Chinese office added.

Several Taiwan politicians have said the need for the Fosun
shots was so urgent the government should bring them in.

But Taiwan's Health Minister Chen Shih-chung told a daily
news briefing Taiwan had seen no supporting documentation about
Fosun's version of the vaccine.

"Bring out the official documents and we can talk about it
again."
(Reporting by Ben Blanchard and Yimou Lee in Taipei and David
Brunnstrom and Michael Martina in Washington; Editing by
Christopher Cushing, Robert Birsel and Bill Berkrot)

More News
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.